Recombinant adenoviruses are the most efficient vectors with which to perform arterial gene transfer. Previous in vivo studies of adenovirus-mediated arterial transfection, however, have been performed using normal or endothelium-denuded arteries. It is unclear whether these results can be extended to atherosclerotic arteries. Accordingly, this study was designed to (a) assess the feasibility of adenovirusmediated gene transfer to atherosclerotic lesions, and (b) compare the transfection efficiency, anatomic distribution of transfected cells, and duration of transgene expression achieved in normal versus atherosclerotic arteries. A recombinant adenovirus including a nuclear-targeted (-galactosidase gene was percutaneously delivered to the iliac artery of normal (n = 25) and atherosclerotic (n = 25) rabbits. Transgene expression, assessed by morphometric as well as chemiluminescent analyses, was documented in all normal and atherosclerotic arteries between 3 and 14 d after gene transfer, but was undetectable at later time points. Transfected cells were identified as smooth muscle cells located in the media of normal arteries, and in the neointima and the vasa-vasora of atherosclerotic arteries. Two percent of medial cells, but only 0.2% of medial and neointimal cells expressed the transgene in normal and atherosclerotic arteries, respectively (P = 0.0001). Similarly, nuclear ,B-galactosidase activity was higher in normal than in atherosclerotic arteries (3.2 vs. 0.8 mU/mg protein, P = 0.02). These findings indicate that atherosclerosis reduces the transfection efficiency which can be achieved with adenoviral vectors, and thus constitutes a potential limitation to adenovirus-based, arterial gene therapy. (J. Clin. Invest. 1995. 95:2662-2671
Introduction
Replication defective, recombinant adenoviruses are efficient vectors for in vivo arterial gene transfer (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . In a few studies, the transgene, inserted into the adenoviral genome, has been successfully delivered to the arterial wall using a percutaneous approach similar to the procedure used to perform coronary angioplasty (4, 5, 7, 9, 10) . Despite the variation in catheter designs used, the resulting transfection efficiencies have been typically higher than those achieved with retroviral vectors (11, 12) plasmid DNA/liposome complexes (11, 13, 14) , or plasmid DNA alone (15, 16) . It is unclear, however, whether these results, obtained in normal or endothelium-denuded arteries, can be extended to more extensively diseased arteries (17) . This issue is relevant to clinical applications of arterial gene transfer, such as prevention of restenosis or therapeutic angiogenesis, which would more typically require efficient transfection of atherosclerotic arteries. Certain pathologic characteristics of human atherosclerosis can be mimicked in the rabbit iliac artery by the combination of a hypercholesterolemic diet and balloon injury (18) (19) (20) . Accordingly, this model was used in the present study to: (a) investigate the feasibility of percutaneous, adenovirus-mediated gene transfer to atherosclerotic lesions; and (b) compare the transfection efficiency, anatomic distribution of transfected cells, and duration of transgene expression achieved in normal versus atherosclerotic arteries.
Methods

Recombinant adenoviruses
Replication-defective, recombinant adenoviruses based on human adenovirus 5 serotype were constructed, grown, and purified as previously described (21) (22) (23) 
Arterial gene transfer in vivo
New-Zealand white rabbits (weight 4.0-4.5 kg), either normal (n = 25) or hypercholesterolemic (n = 25), were used in this study. Animal protocols were approved by St. Elizabeth's Medical Center Institutional Animal Care and Use Committee. Hypercholesterolemic rabbits were fed a 1% cholesterol diet for 7 wk before gene transfer. This diet resulted in high cholesterol levels at the time of transfection (1453+38 mg/dl), consistent with previous reports (18) . 1 wk after initiation of the diet, focal lesions were induced in both iliac arteries, by balloon de-endothelialization using three passes of a 4F Swan-Ganz balloon catheter introduced through the left carotid artery (adapted from Baumgartner et al. [24] , Leclerc et al. [14] , and Weidinger et al. [20] ). Balloon-angioplasty and transfection are performed simultaneously. Infusion of contrast medium into the balloon inflation lumen delineates balloon contour.
In vivo gene transfer was performed under general anesthesia induced by intra-muscular injection of ketamine (50 mg/kg) and xylazine (10 mg/kg). The local delivery device used in these experiments was a channeled-balloon angioplasty catheter (Mansfield Medical, Boston Scientific Corp., Watertown, MA). This catheter incorporates a conventional, 20-mm-long polyethylene teraphalate balloon covered by a layer of 24 perforated channels which are perfused via an independent lumen (Fig. 1 ). This design is intended to permit low-pressure, local drug delivery simultaneous with high-pressure balloon angioplasty (25) . Balloon diameter was chosen to approximate a 1.0:1.0 balloon/artery ratio based on caliper measurement of magnified angiographic frames.
The catheter was introduced through the right carotid artery over a 0.014 inch guide-wire and advanced into the abdominal aorta. In atherosclerotic rabbits, arterial blood was drawn for determination of total serum cholesterol, and an aorto-iliac angiogram was obtained before gene transfer. The catheter was then advanced into the right external iliac artery, and inflated at nominal pressure (8 atm) immediately distal to the bifurcation between the external and internal iliac arteries. One ml of viral solution (4.109 pfu of Ad-RSV,/gal in saline) was instilled through the infusion port of the catheter under 2 atm pressure using a 10 ml LeVeen Inflator (Medi-Tech, Boston Scientific Corp., Watertown, MA). Infusion time ranged from 90 to 150 s. The infusion pressure was chosen to avoid deep arterial injury (7, 12) and adenovirus dissemination (7) reportedly induced by higher delivery pressure using a porous-balloon system. After 30 min of incubation, the balloon was deflated, a posttransfection angiogram was obtained in atherosclerotic rabbits, and the catheter was removed. The contralateral iliac artery was used as a control: in both the normal as well as the atherosclerotic rabbits, no catheter or virus was introduced in 15 animals, while in the 10 others a channeled-balloon was inflated, and saline (n = 5) or Ad-RSVapoAl (4.109 pfu in 1 ml saline, n = 5) instilled as previously described.
Quantitative angiography
In 10 atherosclerotic rabbits, quantitative analysis of angiograms of the transfected arteries obtained before and after transfection/angioplasty was performed using a computerized arterial analysis system (ImageComm, Inc., Santa Clara, CA), as previously described (26). Luminal narrowing, expressed as percent stenosis, was determined by comparison with the largest lumen diameter distal to the lesion. The transfected segment was analyzed for percent luminal narrowing at the site of most severe focal stenosis, as well as for mean percent luminal narrowing along the entire length of the transfected segment.
Digital planimetry of atherosclerotic lesions
In four atherosclerotic rabbits sacrificed 3 d after gene transfer, eight arterial sections were taken from uninstrumented control arteries harvested as described below, and analyzed by digital planimetry using a computer-assisted morphometric program (MACMEASURE 1.9, Apple) and a graphics digitizing table (SUMMASKETCH; Summagraphics Corp., Austin, TX). The luminal area, as well as the areas bounded by both the internal and external elastic laminae were measured. The neointimal area was calculated by subtraction of the lumen area from the area bounded by the internal elastic lamina. Two indexes of lesion formation were calculated: (a) the ratio of the neointimal to medial area (neointima/media ratio), and (b) the ratio of the neointimal area to the area bounded by the internal elastic lamina (luminal crosssectional area narrowing).
Transfection efficiency 3 d after gene transfer 3 d after gene transfer, 17 normal and 17 atherosclerotic rabbits were killed by pentobarbital overdose. In each group, transfection efficiency was determined by morphometric (n = 10) and chemiluminescent (n = 7) analyses.
Morphometric analyses. Both iliac arteries were perfusion-fixed with 1% paraformaldehyde, harvested, and incubated with the same fixative for an additional 5 min. 6-galactosidase activity was assessed by incubating arteries in X-GAL chromogen (Boehringer Mannheim Corp., Indianapolis, IN) for 2 h at 37TC, as previously reported (2, 9, 27) . This short incubation time was used to avoid detection of nonspecific endogenous /3-galactosidase activity. After staining, arteries were rinsed in saline, post-fixed in 1% paraformaldehyde, and photographed through a dissecting microscope. A 2-cm-long arterial segment, immediately distal to the internal iliac artery, was sectioned into four serial 5-mmlong rings. The rings were subsequently embedded in paraffin, and twelve 6-pm-thick sections were cut from each ring at six different levels throughout the entire length of the ring. Arterial sections were counterstained with hematoxylin and eosin or Richardson's elastic-trichrome and examined through a light microscope. Expression of transfected nlslacZ gene was considered positive only when dark blue nuclear staining was observed.
In both normal and hypercholesterolemic rabbits, 40 arterial rings, representing 480 arterial sections, and more than 500,000 cells were evaluated for transgene expression. In each ring, /-galactosidase activity was assessed on gross examination using a 4-grade semi-quantitative score (0, 1, 2, 3: no, low, intermediate, high f-galactosidase activity, respectively). In each arterial section, transfection efficiency was determined as (a) the percentage of stained versus total medial and neointimal cells per arterial section; and (b) the absolute number of stained medial and neointimal cells per arterial section.
Chemiluminescent assay. Nuclear extracts were prepared from both iliac arteries as described by Schreiber et al (28) . Briefly, arteries were homogenized immediately after sacrifice in ice-cold lysis buffer (10 mM Hepes pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM PMSF). The homogenate was incubated on ice for 15 min, then centrifuged for 30 s in a microfuge. The nuclear pellet was resuspended in ice-cold hyperosmolar buffer (20 mM Hepes pH 7.9,0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF), incubated for 15 min at 4°C on a shaking platform, then centrifuged for 5 min. The supernatant (nuclear extract) was stored at -80°C until use.
,/-galactosidase activity in the nuclear extract was measured using a chemiluminescent assay (GALACTO-LIGHT; Tropix Inc., Bedford, MA) and a LUMAT luminometer (Berthold, Nashua, NH) as previously described (2) . The assay background was determined with the hyperosmolar buffer used for nuclear extraction. The assay was calibrated with a standard curve generated by using purified Escherichia coli ,6-galactosidase (Boehringer Mannheim, specific activity 300 U/mg). The calibration curve was linear from 7.5 to 7500 uU of /3-galactosidase. When light emission was below that produced by 7.5 /tU, fl-galactosidase activity was arbitrarily considered undetectable. All reactions were done in duplicate on 1-and 2-fold dilutions of the nuclear extract. The mean of the two values was used to measure total nuclear f3-galactosidase activity per vessel. Protein content in the nuclear extract was measured using the BIO-RAD protein assay (Bio-Rad, Hercules, CA). Transfection efficiency was expressed as (a) nuclear /3-galactosidase activity normalized to the nuclear protein content; and (b) total nuclear /3-galactosidase activity per vessel.
Immunohistochemistry
To determine which cell types within the arterial wall expressed the transgene, immunohistochemical staining of X-gal-stained arterial sections was performed using, as a primary antibody, a mouse monoclonal antibody specific for either smooth muscle a-actin (HHF-35; Enzo Diagnostics, Farmingdale, NY), or macrophages (RAM-l 1; Dako, Carpintiera, CA), and then a polyclonal peroxidase-labeled (Signet Laboratories, Dedham, MA) or alkaline phosphatase-labeled (Biogenex, San Ramon, CA) anti-mouse immunoglobulin G secondary antibody.
Duration of transgene expression
To compare the duration as well as the kinetics of transgene expression in normal and atherosclerotic arteries, additional normal (n = 8) and atherosclerotic (n = 8) rabbits were included in a time-course study. In these animals, /3-galactosidase activity was measured in nuclear extracts from transfected arteries harvested 3, 7, 14, and 21 d after gene transfer (n = 2 in each group and at each time-point), using the chemiluminescent assay described above.
Detection of extra-arterial transfection
In five normal and five atherosclerotic rabbits sacrificed 3 d after transfection, tissue samples from liver, brain, testes, lung, myocardium, kidney, and right limb skeletal muscle ipsilateral to the transfected artery were harvested immediately after sacrifice. For each specimen, nlslacZ gene presence and expression were assessed by optimized polymerase chain reaction (PCR) and histochemical staining (X-gal), respectively. PCR protocol. DNA was extracted from tissues by standard techniques. DNA amplification was carried out in presence of 32P-radiolabeled dCTP using oligonucleotide primers designed to selectively amplify Ad-RSVflgal DNA over the endogenous /3-galactosidase gene by placing one primer in the adenovirus sequence coding for protein 9 and the other primer in the nlslacZ sequence as previously described (9) . Amplification products were detected on 1% agarose gel stained with ethidium bromide as well as by autoradiography. When PCR was performed on the recombinant plasmid pAd-RSV/3gal used for the preparation of Ad-RSV,3gal (22) 
Summary of transfection experiments
A total of 25 normal and 25 atherosclerotic rabbits were studied. In each group, the right iliac artery was transfected with the Ad-RSV/3gal vector, and the left iliac artery served as the control (uninstrumented, n = 15; transfected with the control vector Ad-RSVapoAl, n = 5; sham-transfected with saline alone, n = 5). In each group, transfection efficiency was measured 3 d after gene transfer in 17 rabbits by morphometric (n = 10) and chemiluminescent (n = 7) analyses. In 10 of these animals (normal, n = 5; atherosclerotic, n = 5), extra-arterial transfection was investigated. The time-course of transgene expression was studied in 16 additional rabbits (normal, n = 8; atherosclerotic, n = 8).
Statistical analyses
Values are expressed as meantstandard error of the mean (m±SEM). Comparisons of quantitative angiographic parameters before and after angioplasty were made using a paired Student's t test. Transfection efficiencies achieved in normal and hypercholesterolemic rabbits were compared using a non-parametric test (Mann-Whitney U-test) since these data were not normally distributed (29) . A value of P < 0.05 was accepted to denote statistical significance.
Results
Quantitative angiographic analyses
In atherosclerotic rabbits, balloon angioplasty performed at the time of transfection resulted in significant reduction of maximal and mean luminal diameter narrowing from 63.5±2.6% to 33.2±2.1% (P < 0.001), and from 33.8±2.7% to 27 (Fig. 2) . Transfection was successful in all normal arteries (10/10). Gross examination after X-gal staining showed intense blue staining over the entire length of the luminal aspect of the angioplasty site (Fig. 2 A) . In one rabbit, low ,/-galactosidase activity was also found in the common and the internal iliac arteries ipsilateral to the transfected site. Microscopic examination of the transfected sites confirmed consistent endothelium denudation in all cases, while continuity of the internal elastic membrane and the integrity of the underlying tunica media were consistently preserved (Fig. 2 E) . Dark blue nuclear staining was present, not only in superficial (Fig. 2 C) , but also in deeper cell layers of the media (Fig. 2 D) (Fig. 2 F) . fl-galactosidase activity was undetectable in control arteries (Fig. 2 B) . No evidence of injury to the arterial wall attributable to the channeled-balloon (e.g., jetinduced macro-or microscopic injury) was observed on gross or light microscopic examination.
Atherosclerotic arteries (Figs. 3 and 4) . Gross examination disclosed concentric stenotic lesions. Arterial dissection and plaque fractures were present in 8/10 and 9/10 rabbits, respectively. All arteries (10/10) showed evidence of transgene expression. In contrast with normal arteries, however, f3-galactosidase activity was present only in scattered foci over the neointima (Fig. 3 A) (less than 10 cells/high power field), located in the superficial showing higher transfection efficiency (Fig. 3 D) . Immunohistolayers of the neointima (Fig. 3 C) infiltration in the outermost layers of the neointima and in the media (Figs. 3, E and F), as previously reported (18, 20, 30 (Fig. 4) , the probable route for adventitial transfection. No evidence of,-galactosidase activity was found in control arteries (Fig. 3 B) .
Transfection efficiency 3 d after gene transfer
Morphometric analysis. Using a semi-quantitative score to approximate regional transfection efficiency on gross examination of arterial rings from transfected arteries, the mean transfection scores were 2.1+0.2 and 0.6±0.1 in normal (n = 40 rings) and atherosclerotic (n = 40 rings) arteries, respectively (P = 0.0001). Transfection efficiency was also determined quantitatively by counting stained versus total medial and neointimal cells in each arterial section (Fig. 5) . In normal arteries (n = 480 sections), (Fig. 6) . Nuclear 6-galactosidase activity was detected in each normal (n = 7) as well as atherosclerotic (n = 7) artery transfected with the Ad-RSV/3gal vector. Typically, the level of nuclear /3-galactosidase activity was 20-100-fold over background. In both groups, light emission generated by nuclear extracts from control arteries in the presence of the chemiluminescent substrate was below that generated by 7.5 ILU of 13-galactosidase. Therefore, nuclear f3-galactosidase activity in control arteries was considered undetectable. Transfection efficiency was significantly higher in normal than in atherosclerotic arteries when expressed as nuclear 6-galactosidase activity normalized to the nuclear protein content (3.2 vs. 0.8 mU/mg protein, P = 0.02), as well as nuclear /3-galactosidase activity per vessel (0.70 vs. 0.20 mU/vessel, P = 0.02).
Duration oftransgene expression (Fig. 7) . ,1-gal, 63-galactosidase; *P = 0.02.
neointima as well as in the vasa-vasora; (c) duration of transgene expression in atherosclerotic as well as normal arteries is limited to a 2-wk period after gene transfer; and (d) the potential risk of extra-arterial adenovirus distribution is not increased in atherosclerotic arteries as compared with normal arteries. Adenovirus-mediated, genetic modification of arterial cells has been proposed as a potential strategy to prevent recurrent narrowing (restenosis) following balloon-angioplasty (31). Indeed, Ohno et al recently reported that local delivery of a recombinant adenovirus expressing the herpes virus thymidine kinase at the site of balloon-injury may successfully inhibit smooth muscle cell proliferation and associated neointima formation in the iliac artery of non-atherosclerotic pigs exposed to the nucleoside analog ganciclovir (8) . Given that the protein products of genes selected for their anti-proliferative effects typically remain intra-cellular (8, 32, 33) (9) . In atherosclerotic arteries, transduced cells were identified as smooth muscle cells located predominantly in the superficial layers of the neointima. Adventitial transfection was detected frequently in atherosclerotic but not in normal arteries, and was typically associated with transgene expression in the smooth muscle cells of the vasa-vasora, the probable route for adenovirus distribution to the adventitia. The percentage of transfected neointimal and medial cells, however, was 10-fold lower in atherosclerotic than in normal arteries. The twofold increase in cellularity resulting from neointima formation in atherosclerotic arteries (data not shown), alone, cannot account for this result. Indeed, the absolute number of transfected cells in the media and the neointima of atherosclerotic arteries was 6-fold lower than in the media of normal arteries.
In contrast to the 10-fold reduction in the percentage of transfected neointimal and medial cells in atherosclerotic arteries, the calculated magnitude of nuclear 3-galactosidase activity was only 3-fold lower in atherosclerotic than normal arteries. There are two possible explanations for this discrepancy. First, the assay of enzyme activity may simply be more sensitive than histochemical identification of successful cellular transfection. 2668 Feldman et al. Second, the total nuclear /-galactosidase activity which was measured for atherosclerotic arteries represents not only neointimal and medial but also adventitial P-galactosidase activity.
The lower transfection efficiency achieved in atherosclerotic arteries may result from certain topographical and compositional characteristics of the neointimal lesion induced by balloon-injury and hypercholesterolemia. Morphometric and quantitative angiographic analyses showed that intimal thickening covered 100% of the luminal circumference, resulting in 63.5% maximal luminal diameter narrowing, 65.2% cross-sectional area narrowing, and a neointima/media ratio of 1.7 The duration of gene expression in the study by French et al. was determined only for normal arteries; despite the apparent reduction in transfection efficiency achieved for atherosclerotic versus normal arteries in the present study, the duration of gene expression we observed for atherosclerotic arteries (2 wk) was similar to that reported by French et al. for normal arteries.
The amphotropic nature of the adenovirus has made it useful for gene transfer strategies in a wide variety of tissue types. (21) (22) (23) (36) (37) (38) (39) (40) (41) (42) (43) (44) . Consequently, the capability of preserving site-specific arterial transfection constitutes a relevant consideration for catheter systems designed for local delivery of adenoviral vectors. Moreover, in atherosclerotic arteries, extra-arterial distribution of adenoviruses is more likely to occur via the well developed vasa-vasora (45) and the peri-adventitial tissues. In the current report, however, low-level extra-arterial gene transfer was detected in only one case, that being a normal rabbit. In this one animal, transgene expression was present not only at the transfected site, but also proximally, in the common and internal iliac arteries; the latter were probable routes for extraarterial transfection. In this respect, our findings are consistent with previous observations suggesting that in the absence of extensive angioplasty-induced dissection, adenovirus dissemination is typically undetectable after percutaneous gene transfer to atherosclerotic porcine coronary arteries (10) .
Extrapolation of the findings reported here for the neointimal lesion induced by arterial injury in the hypercholesterolemic rabbit, to the atherosclerotic lesion responsible for arterial narrowing in humans must be undertaken with some caution. Certain features of advanced primary atherosclerotic lesions in humans are not typical features of lesions generated in this particular animal model. In most cases however, these featuresfibrous cap, calcific deposits, greater proportion of matrix versus cells-might be expected to further compromise adenoviral transduction of atherosclerotic arterial sites. Hence, transfection efficiency in the primary atherosclerotic lesion of humans could be even lower than was observed in the present animal model. Such relatively low transfection efficiency achieved at sites of luminal narrowing may compromise certain clinical applications, particularly those involving genes which encode for proteins which remain intracellular (34) . Simple augmentation of the "dose" of vector used may not be the appropriate solution to this problem, in as much as delivery of viral titers > 1010 pfu/ml has been shown to induce cytopathic effects and medial necrosis (2, 46) . Alternatively, adjunctive means designed to optimize adenovirus-mediated gene transfer, such as the use of polymers (pluronic gel) added to the adenoviral solution (47, 48) , warrant further evaluation.
